Home
Resources
Diseases
COVID-19
Hepatitis B
Human papillomavirus (HPV)
Malaria
Measles
Mpox
Pneumococcal disease
RSV (Respiratory syncytial virus)
Compendium
Hexavalent vaccines
HPV vaccines
Malaria vaccines
PCV vaccines
RSV vaccines
Training
Vaccine Portfolio Optimization and Prioritization (VPOP)
Evaluation
The Tool
The Tutorial
The Dashboard
SYSVAC
About
Registry
E-learning courses
News
Webinars
Network
Steering Committee
Vision and Mission
Map
Meetings
Partners
Join us
Home
Resources
Resources
Type of publications
Guidelines (40)
NITAG documentation (1641)
Reports (63)
SAGE documentation (226)
Scientific publications (122)
Systematic reviews (SYSVAC) (3100)
Regions
Africa (297)
Americas (794)
Eastern Mediterranean (58)
Europe (744)
Global (1)
South-East Asia (82)
Western Pacific (216)
Diseases
Chikungunya (13)
Cholera (35)
COVID-19 (1589)
Cytomegalovirus (1)
Dengue (43)
Diphtheria (90)
Ebola (19)
Escherichia coli (ETEC) (2)
Haemophilus influenzae type B (71)
Hepatitis A (69)
Hepatitis B (171)
Hepatitis C (5)
Hepatitis E (5)
Herpes simplex (1)
Herpes zoster (77)
HIV / AIDS (10)
Human papillomavirus (HPV) (537)
Influenza (629)
Japanese encephalitis (34)
Lyme disease, Borreliosis (2)
Malaria (33)
Measles (144)
Meningococcal disease (155)
Moraxella catarrhalis (1)
Mpox (58)
Mumps (50)
Pertussis (120)
Pneumococcal disease (305)
Poliomyelitis (94)
Q fever (1)
Rabies (33)
Rotavirus (121)
RSV (Respiratory syncytial virus) (69)
Rubella (69)
Salmonella (3)
Shigella (1)
Smallpox (16)
Streptococcus group B (6)
Tetanus (71)
Tick-borne encephalitis (14)
Tuberculosis (83)
Typhoid (32)
Varicella (77)
Yellow fever (44)
Zika (1)
Show more
5192 results found
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: BioNTech/Pfizer
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: Janssen vaccine
2021
∙
Health Council of the Netherlands
COVID-19 vaccination: The Moderna vaccine and the vaccination strategy
2021
COVID-19 vaccination: The Moderna vaccine and the vaccination strategy
2021
∙
ACIP
COVID-19 Vaccine Implementation
2021
∙
Grace M Lee, ACIP
COVID-19 Vaccine Safety Technical (VaST) Subgroup
2021
∙
Grace M Lee, ACIP
COVID-19 Vaccine Safety Technical (VaST) Subgroup - discussion & interpretation
2021
∙
Grace M Lee, ACIP
COVID-19 Vaccine Safety Technical (VaST) Subgroup - discussion and interpretation
2021
∙
ACIP, Grace M Lee
COVID-19 Vaccine Safety Technical (VaST) Subgroup - March 1st 2021
2021
∙
Tom Shimabukuro, ACIP
COVID-19 vaccine safety update
Home
Resources
Diseases
Compendium
Training
Evaluation
SYSVAC
News
Webinars
Network
Sign in / Register
